17.21
price down icon0.52%   -0.09
after-market Dopo l'orario di chiusura: 17.21
loading

Bausch Lomb Corp Borsa (BLCO) Ultime notizie

pulisher
04:43 AM

Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - GlobeNewswire Inc.

04:43 AM
pulisher
Jan 08, 2026

Will Bausch + Lomb Corporation (S2L) stock benefit from Fed rate cutsProduct Launch & Safe Entry Momentum Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Bausch + Lomb (NYSE:BLCO) Rating Lowered to "Hold" at Evercore ISI - MarketBeat

Jan 06, 2026
pulisher
Jan 06, 2026

Bausch + Lomb (NYSE:BLCO) Valuation Check After Mixed 90 Day And 1 Year Shareholder Returns - Yahoo Finance

Jan 06, 2026
pulisher
Jan 05, 2026

Evercore Downgrades Bausch + Lomb Corp.(BLCO.US) to Hold Rating, Cuts Target Price to $18 - 富途牛牛

Jan 05, 2026
pulisher
Jan 05, 2026

Bausch + Lomb Corporation (BLCO): Investor Outlook on Growth Potential and Strategic Positioning - DirectorsTalk Interviews

Jan 05, 2026
pulisher
Jan 05, 2026

Glaucoma stories and research drive new Bausch + Lomb awareness push - Stock Titan

Jan 05, 2026
pulisher
Jan 02, 2026

Bausch & Lomb CorpEnters fourth amendment to credit agreement dated as of May 10, 2022SEC filing - marketscreener.com

Jan 02, 2026
pulisher
Jan 02, 2026

Bausch + Lomb just refinanced $2.8B in debt to cut interest margin - Stock Titan

Jan 02, 2026
pulisher
Jan 02, 2026

Bausch + Lomb Signs Fourth Amendment to Credit Agreement With JPMorgan Chase and Lenders - TradingView — Track All Markets

Jan 02, 2026
pulisher
Dec 29, 2025

Bausch + Lomb (BLCO): Investor Outlook on a Visionary Healthcare Player with a Focused Growth Trajectory - DirectorsTalk Interviews

Dec 29, 2025
pulisher
Dec 25, 2025

Does Bausch + Lomb’s Rising Focus on Eye Health Make Its Current Share Price Attractive? - simplywall.st

Dec 25, 2025
pulisher
Dec 23, 2025

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Dec 23, 2025
pulisher
Dec 23, 2025

Top eye-care leaders to speak at J.P. Morgan's big healthcare event - Stock Titan

Dec 23, 2025
pulisher
Dec 22, 2025

[8-K/A] Bausch & Lomb Corp Amends Material Event Report | BLCO SEC FilingForm 8-K/A - Stock Titan

Dec 22, 2025
pulisher
Dec 21, 2025

Bausch + Lomb Corporation (NYSE:BLCO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Dec 21, 2025
pulisher
Dec 20, 2025

Will Bausch + Lomb Corporation stock keep outperforming rivalsMarket Trend Summary & Reliable Breakout Forecasts - Улправда

Dec 20, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-18 17:17:15 - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Icahn Money Manager Sues His Bosses and Bausch + Lomb Over Anti-White Bias - Insurance Journal

Dec 18, 2025
pulisher
Dec 18, 2025

Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year - The Globe and Mail

Dec 18, 2025
pulisher
Dec 18, 2025

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans - VisionMonday.com

Dec 18, 2025
pulisher
Dec 17, 2025

Bausch + Lomb appoints two new directors to board effective January - Investing.com

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb Adds New Directors to Board - TipRanks

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch & Lomb Corp Announces Board Appointments - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb appoints two new directors to board effective January By Investing.com - Investing.com South Africa

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb (NYSE: BLCO) appoints Eduardo Alfonso and Steven Collis to board - Stock Titan

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb Brief: Appointing Eduardo C. Alfonso, and Steven H. Collis To Its Board, Effective Jan. 1, 2026; Board Will Then Be Comprised of 10 Directors - marketscreener.com

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb Announces Two Board Of Directors Appointments - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 17, 2025

Leading eye specialist and Fortune 10 CEO join Bausch + Lomb board - Stock Titan

Dec 17, 2025
pulisher
Dec 17, 2025

Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year - The Motley Fool

Dec 17, 2025
pulisher
Dec 17, 2025

Bausch + Lomb Corporation's (NYSE:BLCO) Prospects Need A Boost To Lift Shares - 富途牛牛

Dec 17, 2025
pulisher
Dec 17, 2025

Large-Scale Debt Refinancing And Pipeline Optimism Might Change The Case For Investing In Bausch + Lomb (BLCO) - simplywall.st

Dec 17, 2025
pulisher
Dec 17, 2025

(BLCO) Strategic Equity Report (BLCO:CA) - news.stocktradersdaily.com

Dec 17, 2025
pulisher
Dec 16, 2025

America First Legal Files Lawsuit Against Bausch + Lomb for Racial Discrimination in Board Appointments - America First Legal

Dec 16, 2025
pulisher
Dec 16, 2025

Icahn money manager sues his bosses and Bausch + Lomb over anti-white bias - MSN

Dec 16, 2025
pulisher
Dec 15, 2025

Bausch + Lomb: I Need To See Stability Before Upgrading This Name (BLCO) - Seeking Alpha

Dec 15, 2025
pulisher
Dec 15, 2025

Nomura Holdings Inc. Cuts Holdings in Bausch + Lomb Corporation $BLCO - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Bausch + Lomb (NYSE:BLCO) valuation after analyst upgrades highlight confidence in growth and margin improvement - simplywall.st

Dec 15, 2025
pulisher
Dec 14, 2025

Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt - MSN

Dec 14, 2025
pulisher
Dec 14, 2025

How Bausch + Lomb’s $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors - Yahoo Finance

Dec 14, 2025
pulisher
Dec 14, 2025

(BLCO) Stock Trading Blueprint (BLCO:CA) - news.stocktradersdaily.com

Dec 14, 2025
pulisher
Dec 12, 2025

Bausch + Lomb Announces $2.8 Billion Loan Refinancing - TipRanks

Dec 12, 2025
pulisher
Dec 12, 2025

Bausch & Lomb Corp Announces Refinancing of Term B Loans - TradingView — Track All Markets

Dec 12, 2025
pulisher
Dec 12, 2025

Bausch + Lomb allocates $2.8 billion to refinance outstanding loans By Investing.com - Investing.com South Africa

Dec 12, 2025
pulisher
Dec 12, 2025

Bausch + Lomb allocates $2.8 billion to refinance outstanding loans - Investing.com

Dec 12, 2025
pulisher
Dec 12, 2025

Bausch + Lomb (NYSE: BLCO) announces $2,802,125,000 term B refinancing with 2031 maturity - Stock Titan

Dec 12, 2025
pulisher
Dec 12, 2025

Bausch + Lomb (NYSE: BLCO) allocates $2,802,125,000 term B loans at 3.75% - Stock Titan

Dec 12, 2025
pulisher
Dec 11, 2025

Citi Upgrades Bausch + Lomb Corp.(BLCO.US) to Buy Rating, Announces Target Price $20 - 富途牛牛

Dec 11, 2025
pulisher
Dec 11, 2025

Bausch + Lomb Shares Rise After Citigroup Upgrade - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

Why Bausch + Lomb (BLCO) Stock Is Trading Up Today - Finviz

Dec 11, 2025
pulisher
Dec 11, 2025

Citigroup Upgrades Bausch + Lomb to Buy From Neutral, Adjusts Price Target to $20 From $16 - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

(BLCO) Market Insights and Trading Signals (BLCO:CA) - news.stocktradersdaily.com

Dec 11, 2025
pulisher
Dec 09, 2025

Bausch + Lomb Corporation $BLCO Stock Holdings Raised by Goldentree Asset Management LP - MarketBeat

Dec 09, 2025
$172.79
price up icon 1.30%
$86.14
price up icon 0.43%
medical_instruments_supplies COO
$83.45
price up icon 0.38%
$74.87
price down icon 0.01%
medical_instruments_supplies WST
$275.52
price up icon 0.11%
$40.52
price down icon 1.77%
Capitalizzazione:     |  Volume (24 ore):